
Fluticasone Furoate + Vilanterol Suppliers & Bulk Manufacturers
Available Forms: Powder For Inhalation(DPI/MDI)
Available Strengths: 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol
Reference Brands: Breo Ellipta®(US), Relvar Ellipta® (EU)
Category: Respiratory Disorder
Fluticasone furoate + Vilanterol is available in Powder For Inhalation(DPI/MDI) and strengths such as 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fluticasone furoate + Vilanterol is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Fluticasone furoate + Vilanterol can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Fluticasone furoate and Vilanterol is a powerful once-daily combination therapy used for the long-term treatment of asthma and chronic obstructive pulmonary disease (COPD). Marketed as Breo Ellipta® in the U.S. and Relvar Ellipta® in the EU, this inhalation powder combines Fluticasone, a corticosteroid that reduces inflammation, with Vilanterol, a long-acting beta-agonist (LABA) that relaxes airway muscles. Available in 92/22 mcg and 184/22 mcg strengths via the Ellipta® DPI, it offers 24-hour symptom control. Ideal for pharma B2B and export markets, this therapy enhances adherence and delivers effective respiratory relief with convenient once-daily dosing.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Ciclesonide
Strength:
37mcg, 80mcg, 160mcg
Form: Nasal Spray / Inhalation
Reference Brands: Zetonna (USA/EU), Alvesco (USA/EU), Omnaris (USA/EU)
View DetailsAlbuterol+Budesonide
Strength:
90mcg+80mcg
Form: Inhalation
Reference Brands: Airsupra (USA)
View DetailsAlbuterol
Strength:
90 mcg, 0.63 mg/3 mL, 1.25 mg/3 mL, 2.5 mg/3 mL
Form: Inhalers/ Nebulizer Solutions
Reference Brands: Ventolin HFA (USA/EU), AccuNeb USA)
View DetailsRiociguat
Strength:
0.5 mg ,1 mg, 1.5 mg, 2 mg, 2.5 mg
Form: Tablets
Reference Brands: Adempas (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers